SB 2586 In Committee
Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Version comparison
3 versionsSign in to read the full text
The document summary and details above are public. The full text is available to signed-in accounts.